01 7GLAXO GRP ENGLAND
02 55GLAXOSMITHKLINE
01 47439393
02 37439393*PED
03 47488827
04 47498440
05 38161968
06 38161968*PED
07 58183257
08 18201556
09 48309572
10 38511304
11 38511304*PED
12 38534281
13 38534281*PED
14 48746242
15 38746242*PED
16 49333310
17 39750726
18 211090294
19 39333310*PED
01 12Y
02 50Blank
01 33Y
02 29Blank
01 82025-04-27
02 42025-05-21
03 52025-07-27
04 32025-11-21
05 32027-06-14
06 42027-10-02
07 32027-12-14
08 42027-12-18
09 32028-02-05
10 32028-04-02
11 32028-08-05
12 12029-02-05
13 32030-03-08
14 32030-09-08
15 42030-10-11
16 52030-11-29
17 32031-04-11
Patent Expiration Date : 2025-07-27
US Patent Number : 8183257
Drug Substance Claim :
Drug Product Claim :
Application Number : 205382
Patent Use Code : U-1476
Delist Requested :
Patent Use Description : INDICATED FOR THE LONG...
Patent Expiration Date : 2025-07-27
Patent Expiration Date : 2025-04-27
FLUTICASONE FUROATE; UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE
US Patent Number : 8309572
Drug Substance Claim :
Drug Product Claim :
Application Number : 209482
Patent Use Code : U-2129
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2025-04-27
Patent Expiration Date : 2025-04-27
US Patent Number : 8309572
Drug Substance Claim :
Drug Product Claim :
Application Number : 205382
Patent Use Code : U-1476
Delist Requested :
Patent Use Description : INDICATED FOR THE LONG...
Patent Expiration Date : 2025-04-27
Patent Expiration Date : 2025-04-27
UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE
US Patent Number : 8309572
Drug Substance Claim :
Drug Product Claim :
Application Number : 203975
Patent Use Code : U-1476
Delist Requested :
Patent Use Description : INDICATED FOR THE LONG...
Patent Expiration Date : 2025-04-27
Patent Expiration Date : 2025-07-27
UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE
US Patent Number : 8183257
Drug Substance Claim :
Drug Product Claim :
Application Number : 203975
Patent Use Code : U-1476
Delist Requested :
Patent Use Description : INDICATED FOR THE LONG...
Patent Expiration Date : 2025-07-27
Patent Expiration Date : 2030-11-29
FLUTICASONE FUROATE; UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE
US Patent Number : 11090294
Drug Substance Claim :
Drug Product Claim :
Application Number : 209482
Patent Use Code : U-3202
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2030-11-29
Patent Expiration Date : 2030-11-29
UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE
US Patent Number : 11090294
Drug Substance Claim :
Drug Product Claim :
Application Number : 203975
Patent Use Code : U-3203
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2030-11-29
Patent Expiration Date : 2025-05-21
FLUTICASONE FUROATE; UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE
US Patent Number : 7439393
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 209482
Patent Use Code : U-2127
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2025-05-21
Patent Expiration Date : 2025-07-27
FLUTICASONE FUROATE; UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE
US Patent Number : 8183257
Drug Substance Claim :
Drug Product Claim :
Application Number : 209482
Patent Use Code : U-2128
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2025-07-27
Patent Expiration Date : 2025-04-27
FLUTICASONE FUROATE; UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE
US Patent Number : 8309572
Drug Substance Claim :
Drug Product Claim :
Application Number : 209482
Patent Use Code : U-2129
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2025-04-27
LOOKING FOR A SUPPLIER?
Market Place
